Models Including Serum CA-125, BMI, Cyst Pathology, Dysmenorrhea or Dyspareunia for Diagnosis of Endometriosis
article
OA: closed
CC0
⤵ 9 in-corpus citations
AI-generated summary
Diagnostic models incorporating serum CA-125, BMI, cyst pathology, and either dyspareunia or dysmenorrhea showed potential for noninvasive endometriosis diagnosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIM: To evaluate preoperative levels of CA-125 and HE4 in patients with endometriosis-like symptoms and to construct diagnostic models. PATIENTS: Prospective case-control study included 124 endometriosis patients and 97 control patients. MATERIALS & METHODS: Logistic regression was used to construct diagnostic models based on serum biomarker levels and clinical data. RESULTS: A model with CA-125, BMI, information on cysts and dyspareunia had an area under the curve value of 0.836, sensitivity of 74.0% and specificity of 81.3%. The second model included CA-125, BMI, information on cysts and dysmenorrhea and had an area under the curve value of 0.819, sensitivity of 74.8% and specificity of 79.2%. CONCLUSION: Constructed models have the potential for noninvasive diagnosis of endometriosis, and might be translated into clinical practice after additional validation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- Biomarker development in endometriosis via openalex
- Biomarkers of endometriosis via openalex
- Blood biomarkers for the non-invasive diagnosis of endometriosis via openalex
- CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results via openalex
- Combination of the non-invasive tests for the diagnosis of endometriosis via openalex
- Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration via openalex
- Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration. via openalex
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis via openalex
- Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis via openalex
- Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis, a modern syndrome. via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Estrogen metabolism and action in endometriosis via openalex
- Immunology and Endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts via openalex
- Theories on the Pathogenesis of Endometriosis via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer via openalex
- The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case–control study via openalex
- Tumor markers and transvaginal ultrasonography in the diagnosis of endometrioma via openalex
- Urological and colorectal complications following surgery for rectovaginal endometriosis via openalex
- Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex
- What makes a good case–control study? via openalex
- W6685238849 via openalex
- W1977001276 via openalex
- W2000186275 via openalex
- W2005006135 via openalex
- W2055527762 via openalex
- W2071020286 via openalex
- W2080420959 via openalex
- W2121044470 via openalex
- W4211081176 via openalex
- W6653017088 via openalex
- W91969275 via openalex
Cited by (9)
- Growth Arrest-Specific Protein 6 Is Elevated in Endometriosis but Shows Poor Diagnostic Performance 2025
- Transcriptome profiling to identify blood biomarkers for peritoneal endometriosis 2025
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms 2023
- Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis 2022
- Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis 2022
- Biomarkers of endometriosis: How far have we come and where are we going? 2021
- The additional diagnostic value of NLR and PLR for CA-125 in the differential diagnosis of endometrioma and benign ovarian cysts in women of reproductive age: a retrospective case-control study 2019
Source provenance
- europepmc
- last seen: 2026-07-03T06:58:25.718087+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:43.094626+00:00
License: CC0
· commercial use OK